However, the situation is different when it comes to non-viral hepatitis. These, in fact, can be caused by chemicals, drugs, or metabolic problems. The therapy for these hepatitis, therefore, depends on the triggering causes.Finally, there are autoimmune hepatitis, which is caused by an incorrect attack of the immune system against liver damage.
The immune defenses, therefore, erroneously attack the organ, thus causing inflammation which, in the long run, can turn into cirrhosis and cause permanent damage to the patient that risks seriously compromising his lifestyle. They are women, the most affected by autoimmune hepatitis, and represent about 70% of patients affected by this pathology.Hepatitis: prevention and lifestyle
As in all pathologies, from a prevention perspective, lifestyle is always of primary importance, which must be free of excesses and active, regulated by a healthy diet and reduced alcohol consumption.
However, when we talk about hepatitis A and B we are talking about diseases for which it is essential to get vaccinated, following the program of the National Health System; as well as, if you are planning a trip to areas considered at risk, it is necessary to follow the health protocols of that particular region.
Finally, a great risk is represented by tattoos and piercings performed in an unsafe environment, for this reason it is essential to always contact professionals of the trade, who work in certified facilities where only suitable tools are used.
How is hepatitis treated?
2020 saw the achievement of new milestones in the treatment of hepatitis B, thanks to the introduction of Tenofovir Alafenamide, a drug with a safety profile higher than that of previous drugs and with good antiviral potency.
In addition, in Humanitas, it is possible to access hepatitis C treatment directly from the facility’s pharmacy, thus halving the waiting time for the patient. For Delta hepatitis, on the other hand, it is possible to access a clinical trial, under the supervision of the specialists of the Internal Medicine and Hepatology Unit, with a drug in an advanced stage of clinical development and with very promising results: Lonafarnib.
28 JUL – World Hepatitis Day is celebrated every year on 28 July to raise awareness of viral hepatitis, an inflammation of the liver that causes severe liver disease and hepatocellular cancer. This year’s theme is “Hepatitis can’t wait” (Hepatitis can’t wait).
With a person dying every 30 seconds of a hepatitis-related disease – even in the current COVID-19 crisis – we can’t wait to act on viral hepatitis. There are five main strains of the hepatitis virus – A, B, C, D and E. Together, hepatitis B and C are the most common, causing 1.1 million deaths and 3 million new infections per year. . A future without hepatitis is achievable with a joint effort.